Evaluation of a Salutogenetic Concept for Inpatient Psychosomatic Treatment

Table 1

The data sets and its underlying patient population are listed for each research question.

Research question	Inventory/data set	Subgroups	Number of patients
Q1	HFV total and 14 items	All patients*	7987 to 8170
Q2	HFV total (i.v.); ISR total effect size (d.v.); VEV-K total change (d.v.)	All patients*	7259; 7843
Q3	ISR (pre + post) (total + subscales); VEV-K (total + 3 subscales); GV (total and 4 subscales)	All patients*	Up to 8068
Q4	ISR total effect size; VEV-K total change	Patients in 13 paths*	38 to 6962; 41 to 7457
Q5	ISR pre + follow up; VEV-K (total + 3 subscales) followup; GV (total and 4 subscales) followup	Follow-up return*	Up to 1046
Q6	ISR (pre + post) (total + subscales); VEV-K (total); GV (all 11 items)	Patients in 2011	1181 (HF); 5348 (other clinics)

 *As many patients as possible were included who completed the particular questionnaire scale partly or fully. i.v.: independent variable; d.v.: dependent variable.